Anthony V. Lemmo, CEO of BioDot discusses the demand for COVID-19 tests and the diagnostic manufacturing communities ability to scale-up production.
To read the full article go to:
https://www.barrons.com/articles/covid-19-test-demand-will-break-global-capacity-without-immediate-investment-51596223970